Concepedia

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

Mark A. Dickson, Manish A. Shah, Dana E. Rathkopf, Archie Tse, Richard D. Carvajal, Nian Wu, Robert A. Lefkowitz, Mithat Gönen, Lauren M. Cane, H. Dials,

Cancer Chemotherapy and Pharmacology · 2010 · 29 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

David Cunningham, Yves Humblet, Salvatore Siena et al. · New England Journal of Medicine · 2004 · 5K citations · Full text

, , +17

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet · 2000 · 3.3K citations

, , +13

Distinct Sets of Genetic Alterations in Melanoma

John A. Curtin, Jane Fridlyand, Toshiro Kageshita et al. · New England Journal of Medicine · 2005 · 2.7K citations · Full text

, , +14

Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.

Bradley A. Carlson, M M Dubay, Edward A. Sausville et al. · PubMed · 1996 · 537 citations

, , +14

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

Manish A. Shah, Gary K. Schwartz · PubMed · 2001 · 440 citations

, , +17